We are thrilled to invite you all to the first MNSCT workshop. The program is planned by a scientific committee from the Swedish-Norwegian BMT-group and the Swedish AML-group. The overarching aim of this meeting is to stimulate discussions around topics within the Nordic community. Please register for this event using this link (deadline 2023-10-27). Click here for more […]
Agenda Download a recorded version of the webinar using this link. Find the HCP guide for Ceplene on this link. Ceplene can be ordered with the Nordic item number (Vnr.) 46 54 33, through: Oriola in Sweden TMJ in Denmark Your local wholesaler, Apotek 1, NMD and Alliance in Norway --------------------------------------------- AML patients not candidates to […]
Link and passcode for Teams meeting sent separately. Agenda: Update on potential LD-VenEx amendment trial comparing poDEC/LD-VenEx vs. AZA/LD-VenEx (5 min + 10 min discussion). NAMLG – platform trial structure concept (5 min): Infrastructure with standing collaboration contracts (clinical trial agreement – CTA) and data processing agreements (DPAs) applicable for all types of trials. This […]
Webinar to be held January 25 at 16:00 This is in Standard Biotools’ (former Fluidigm) Scientist in the Spotlight series. More info and registration on this link. Hear about: Insights into AML response: Discover the initial signaling response to standard induction chemotherapy in a cohort of 32 AML patients. Predicting 5-year survival: Learn about the significant predictors of patient […]
Nordic AML posters at ASH 2023 - Webinar - 2024-03-12 - 15:00-16:20 (CET) Join us for a webinar where we delve into the intricacies of showcased Nordic AML posters at the latest ASH Annual Meeting in December 2023. Here we aim for an opportunity to gain valuable insights, connect with peers, and stay at the […]
Dr. Mika Kontro will discuss the methods for personalizing AML therapies using functional screening. He will provide an overview of the current data implementation and share insights from ongoing prospective trials employing functional screening. Furthermore, Dr. Kontro will focus on the VenEx trial, which utilizes ex vivo drug sensitivity testing to identify AML patients who […]
For more information, please contact Vladimir Lazarevic, Lund, Sweden. Join via Teams using this link.
Join via Teams using this link.
NAMLG lunch meeting to be held in Sponsor Meeting Hub (in Hall 9) between 11:30 and 13:30 on Saturday 15th June. Preliminary agenda 11:30-11:35: Welcome, v. Bjørn-Tore Gjertsen, Chairman 11:35-11:45 Remarks from the sponsor v. Delbert Pharma 11:45-12:25: NAMLG activities: 11:45-11:55: Scientific working group, Sören Lehmann 11:55-12:05: Educational working group, Albin Österroos/Daniel Tuyet Kristensen 12:05-12:25: […]
Join the opening symposium of the new KG Jebsen Centre for Myeloid Blood Cancer, C-MYC, on September 11 and 12, 2024 in Bergen! Find the program and register using this link.
Find more information via this link. Join the workshop online, by using this Zoom link: https://nanoporetech.zoom.us/j/88211217159?pwd=vlPpfbolZ8bd9kQgQ4Vdi5kytU7Bbb.1 Passcode: 145047 or join in place at this location: Auditorium 2 & 4, BB-Bygget. Haukeland Universitetssykehus - Jonas Lies vei 91. 5009 Bergen
The NAMLG’s Educational Working Group is hosting a webinar on September 24, 2024, from 15:00 to 16:30 CEST. The webinar will provide the latest insights on using Aza-Ven in AML treatment including discussions from a Nordic perspective. Topics will include its application as a first-line treatment, dosing optimizations, and strategies for maintenance therapy. You can […]